Related Experiment Video
Updated: Mar 18, 2026

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Severe, persistent, and fatal T-cell immunodeficiency following therapy for infantile leukemia
Ashley V Geerlinks1, Thomas Issekutz2, Justin T Wahlstrom3
1Department of Pediatrics, IWK Health Centre, Dalhousie University, Halifax, NS, Canada. Ashley.geerlinks@iwk.nshealth.ca.
Insights
Infants completing chemotherapy for acute lymphoblastic leukemia (ALL) can develop severe T-cell immunodeficiency. This serious complication requires early consideration in ALL survivors to prevent opportunistic infections and mortality.
Area of Science:
- Pediatric Oncology
- Immunology
- Hematology
Background:
- Infantile acute lymphoblastic leukemia (ALL) requires intensive chemotherapy regimens.
- Post-chemotherapy immune recovery can be complex in pediatric patients.
Observation:
- Five children diagnosed with severe T-cell immunodeficiency post-chemotherapy for infantile ALL.
- Observed near absence of CD3(+), CD4(+), and CD8(+) T-cells.
- Patients exhibited varying B-cell and NK-cell depletion.
Findings:
- All affected children developed multiple opportunistic infections.
- Four out of five patients succumbed to the condition.
- One patient achieved successful recovery through hematopoietic stem cell transplantation.
Implications:
- Chemotherapy for infantile ALL can precipitate life-threatening secondary immunodeficiencies.
- Early recognition and management of T-cell depletion are crucial for ALL survivors.
- Hematopoietic stem cell transplantation offers a potential treatment avenue for severe cases.
Abstract:
We describe five cases of children who completed chemotherapy for infantile acute lymphoblastic leukemia (ALL) and soon after were diagnosed with severe T-cell, non-HIV immunodeficiency, with varying B-cell and NK-cell depletion. There was near absence of CD3(+) , CD4(+) , and CD8(+) cells. All patients developed multiple, primarily opportunistic infections. Unfortunately, four patients died, although one was successfully treated by hematopoietic stem cell transplantation. These immunodeficiencies appeared to be secondary to intensive infant ALL chemotherapy. Our report highlights the importance of the early consideration of this life-threatening immune complication in patients who received chemotherapy for infantile ALL.
More Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
14:14Simultaneous Quantification of T-Cell Receptor Excision Circles TRECs and K-Deleting Recombination Excision Circles KRECs by Real-time PCR
Published on: December 6, 2014
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cell-mediated Immune Responses
Cytomegalovirus Disease
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...